Treatment of Duodenitis
For duodenitis, test for H. pylori and eradicate if positive using triple therapy (PPI + two antibiotics for 7 days), as H. pylori is present in virtually all cases of erosive duodenitis and eradication achieves healing in 86% of patients.
H. Pylori Testing and Eradication
The cornerstone of duodenitis treatment is identifying and treating H. pylori infection. Research demonstrates that 100% of patients with erosive duodenitis are H. pylori positive 1. This makes duodenitis essentially a variant form of duodenal ulcer disease requiring the same treatment approach.
Recommended Eradication Regimen
Use omeprazole 20 mg twice daily plus two antibiotics for 1 week 1:
- Clarithromycin 500 mg twice daily + amoxicillin 1 g twice daily, OR
- Clarithromycin 500 mg twice daily + metronidazole 500 mg twice daily
This achieves:
- 86% eradication rate (95% CI 75-93%)
- 86% duodenal erosion healing when eradication successful
- Only 37% healing when eradication fails (P < 0.01)
H. pylori eradication is the only variable that independently correlates with erosion healing (odds ratio 10; P < 0.01) 1.
Acid Suppression Strategy
After completing H. pylori eradication therapy:
Uncomplicated duodenitis: Do NOT prolong PPI therapy after eradication treatment 2. The evidence shows prolonged acid inhibition is unnecessary once H. pylori is successfully eradicated.
If eradication fails: Continue PPI therapy as acid suppression provides benefit even without successful eradication 2.
Alternative Acid Suppression (if PPI unavailable)
H2-receptor antagonists show efficacy:
- Standard-dose H2-blockers (cimetidine, ranitidine) reduce duodenal ulcers but are less effective than PPIs 3
- Double-dose H2-blockers may be effective, particularly in H. pylori-positive patients 3
- Cimetidine shows 65% clinical response rate in duodenitis 4
- Nizatidine 150 mg twice daily provides continuous 24-hour acid inhibition 5
Confirmation of Eradication
Perform urea breath test (UBT) or validated monoclonal stool antigen test at least 4 weeks after completing treatment 2. Do NOT use serology for follow-up.
Critical Timing
- Minimum 4 weeks post-treatment (Evidence level: 2b) 2
- Ensures accurate assessment of eradication success
- Relapse within 6 months typically represents recurrence of same infection, not reinfection
Clinical Outcomes with Successful Treatment
When H. pylori eradication is achieved 1:
- 79% overall duodenal erosion healing at 1 month
- Complete symptom resolution in all previously symptomatic patients at 6 months
- Histological improvement in gastric antrum and body (P < 0.001)
- Normal endoscopy in 86% of patients with persistent erosions at 6-month follow-up
Common Pitfalls to Avoid
Do not treat duodenitis empirically without H. pylori testing - The near-universal association demands confirmation and eradication
Do not use serology for post-treatment confirmation - Only UBT or stool antigen tests are validated 2
Do not test too early - Wait minimum 4 weeks to avoid false-positive results from residual inflammation
Do not continue long-term PPI in uncomplicated cases - This is unnecessary after successful eradication and represents overtreatment 2
Do not assume symptom relief equals eradication - Always confirm with objective testing
Special Considerations
For rare non-H. pylori duodenitis (e.g., associated with inflammatory bowel disease): Consider JAK inhibitors like upadacitinib, which has shown efficacy in gastroduodenal ulcerative colitis-related duodenitis 6, 7. However, this represents a completely different disease entity requiring specialist management.
For eosinophilic duodenitis: Requires elimination diet or elemental formula, not antimicrobial therapy 8.